Daxor (FRA:DX5) Margin of Safety % (DCF Earnings Based): N/A (As of Aug. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:DX5 Daxor Corp FRA:DX5
51 GF Score
Price €7.90
GF Value €29.07
Valuation Possible Value Trap
! 1 Warning Sign
View Full Analysis

What is Daxor Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Daxor's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

FRA:DX5 vs POCI, NEPH, MLSS: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Instruments & Supplies subindustry, Daxor's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Daxor Margin of Safety % (DCF Earnings Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Daxor's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Daxor's Margin of Safety % (DCF Earnings Based) falls into.


FRA:DX5
51GF Score
Daxor Corp FRA:DX5
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Daxor (FRA:DX5) Overvalued in 2026?

Based on GuruFocus' analysis, Daxor stock appears to be undervalued. The current stock price of €7.90 is trading 72.8% below its estimated GF Value™ of €29.07. GuruFocus considers Daxor to be Possible Value Trap.

Key valuation signals for FRA:DX5:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: €29.07 vs. price of €7.90 (72.8% below fair value)
  • GF Score™: 51/100 with 1 warning sign

No single metric tells the full story. See the FRA:DX5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Daxor Business Description

Other Exchanges DXR:USA
Address 107 Meco Lane, Oak Ridge, TN, USA, 37830
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.
51GF Score

Get the complete analysis for FRA:DX5

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.90
Price
€29.07
GF Value